Merck to acquire Acceleron Pharma, strengthening cardiovascular pipeline
Merck (MSD outside the US and Canada) will acquire Acceleron in a deal worth around $11.5bn.
Archives for September 30, 2021
Europe to get new cell culture media hub: Fujifilm site to go live in late 2021
Fujifilm Irvine Scientific Inc has started the commissioning phase of its new 250,000 square feet (22,800 square meter) cell culture media manufacturing facility in Tilburg, the Netherlands; the site joins existing plants in the US and Japan.
Pharma CEO confidence tops pre-pandemic levels, companies look to nucleic-acid technology assets to fuel growth
CEOs at large pharma and biotech companies are upbeat when it comes to their outlook for both their own company and the industry at large; they also have a healthy appetite for M&A, found a KPMG survey.
AstraZeneca to fully acquire Caelum Biosciences, advancing mAb for rare disease
AstraZeneca’s Alexion has exercised its option to acquire all remaining equity in Caelum Biosciences for CAEL-101, a fibril-reactive monoclonal antibody (mAb) for the treatment of light chain (AL) amyloidosis.